Consensus on Indications for Hematopoietic Stem Cell Transplantation in Pediatrics. Update 2020: Sarcomas, Ewing Family Tumor, Osteosarcoma and Hepatoblastoma

V Meeting of Brazilian Guidelines on Hematopoietic Stem Cell Transplantation of the Brazilian Society of Bone Marrow Transplantation – SBTMO

Authors

  • Claudio Galvao de Castro Junior Instituto Hemomed de Oncologia e Hematologia

DOI:

https://doi.org/10.46765/2675-374X.2021v2n4p143

Keywords:

Sarcomas, Ewing Sarcoma, Rhabdomyosarcoma, Osteosarcoma, Hepatoblastoma, Hematopoietic Stem Cell Transplantation, Pediatric

Abstract

The indications for hematopoietic stem cell transplantation in solid tumors in children do not change a lot since our first Brazilian consensus publication in 2009.  In this article, we are going to review indications to hematopoietic stem cell transplantation in solid tumors, including the ones that had no more virtual indications.

For the consensus, a review was made using the most relevant articles, and a series of meetings was done to discuss the recommendations.

Downloads

Published

11/30/2021

How to Cite

Galvao de Castro Junior, C. (2021). Consensus on Indications for Hematopoietic Stem Cell Transplantation in Pediatrics. Update 2020: Sarcomas, Ewing Family Tumor, Osteosarcoma and Hepatoblastoma : V Meeting of Brazilian Guidelines on Hematopoietic Stem Cell Transplantation of the Brazilian Society of Bone Marrow Transplantation – SBTMO. JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY, 2(4), 143. https://doi.org/10.46765/2675-374X.2021v2n4p143

Issue

Vol. 2 No. 4 (2021): JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY

Section

Original article

License

Copyright (c) 2021 JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

License and Copyright Policy

The Journal of Bone Marrow Transplantation and Cellular Therapy (JBMTCT) adopts an open access policy, ensuring that all published articles are freely available to the public without restrictions.

  1. License

    • All articles published in JBMTCT are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
    • This license permits anyone to:
      • Share: Copy and redistribute the material in any medium or format.
      • Adapt: Remix, transform, and build upon the material for any purpose, even commercially.
    • The only requirement is that appropriate credit is given to the original authors and source, a link to the license is provided, and any changes made are indicated.

    More information about the license can be found here: Creative Commons Attribution 4.0 International License.

  2. Authors’ Rights

    • Authors retain the copyright to their work.
    • Authors grant JBMTCT the right to publish the work and make it openly accessible online.
    • Authors are free to:
      • Distribute the published version of their article (e.g., post it on personal websites or institutional repositories).
      • Use the article in future works, presentations, or derivative publications, as long as the original publication in JBMTCT is properly acknowledged.

  3. No Embargo

    • There is no embargo period; articles are made freely available immediately upon publication.

  4. Ethical Use

    • Users of JBMTCT articles must ensure proper citation of the authors and the journal.
    • Articles must not be used in ways that violate ethical or legal standards.

  5. Disclaimer

    • While JBMTCT aims to ensure the accuracy and reliability of published content, the journal and its editors are not responsible for the consequences of its use.

For any questions regarding our licensing terms, please contact us at: journalbmtct@sbtmo.org.br 

JBMTCT is committed to the principles of open access to advance knowledge and scientific collaboration.